TY  - BOOK
AU  - Handen,Jeffrey S.
TI  - Industrialization of drug discovery: from target selection through lead optimization 
T2  - Drug discovery series
SN  - 9780824723910 (alk. paper)
AV  - RM301.25 .I53 2005
U1  - 615.19  HAN 
PY  - 2005///
CY  - Boca Raton, London
PB  - Taylor & Francis
KW  - Pharmaceutical industry
KW  - Drug development
KW  - Pharmacology
KW  - thema
KW  - Pharmaceutical chemistry & technology
KW  - Medical research
KW  - Drug Industry
KW  - organization & administration
N1  - Includes bibliographical references and index; Chapter 1.Drug discovery in the modern age: how we got here and what does it mean? -- Chapter 2.The regulatory age -- Chapter 3.Industrialization, not automation -- Chapter 4.Compound management -- Chapter 5.High through-put screening -- Chapter 6.Parallel lead optimization -- Chapter 7.Knowledge management -- Chapter 8.Understanding the value of research -- Chapter 9.Collaboration in a virtual and global environment -- Chapter 10.From genome to drug: ethical issues
N2  - In light of statistics and experience showing that drug discovery and development is getting longer, more expensive, and no better in the sense that the clinical attrition and safety-related market withdrawals today are about the same as they were 20 years ago contributors from pharmaceutical companies and some universities explore a new approach t
ER  -